Literature DB >> 11360275

Prenatal detection of free sialic acid storage disease: genetic and biochemical studies in nine families.

P Salomäki1, N Aula, V Juvonen, M Renlund, P Aula.   

Abstract

Sialic acid storage disorders, Salla disease (SD) and a severe infantile form of disease (ISSD), are recessively inherited allelic lysosomal storage disorders due to impaired egress of free sialic acid from lysosomes. Fourteen pregnancies at risk of adult-type free sialic acid storage disease, SD, were monitored by sialic acid assays, genetic linkage or mutation detection analyses using chorionic villus samples. Three affected and 12 unaffected fetuses were identified. The first studies were based on the sialic acid assays alone, but the location of the gene enabled the use of genetic linkage analysis and, more recently, the identification of the SLC17A5 gene and disease-causing mutations added yet another possibility for prenatal studies. A missense mutation 115C-->T (R39C) is present in 95% of all Finnish SD alleles, providing an easy and reliable means of diagnostic studies. Both molecular and biochemical (sialic acid assay) studies can be used for prenatal diagnosis of free sialic acid storage diseases. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360275     DOI: 10.1002/pd.68

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Clinical, morphological, and molecular aspects of sialic acid storage disease manifesting in utero.

Authors:  R Froissart; D Cheillan; R Bouvier; S Tourret; V Bonnet; M Piraud; I Maire
Journal:  J Med Genet       Date:  2005-04-01       Impact factor: 6.318

3.  A 13-year follow-up of Finnish patients with Salla disease.

Authors:  Liisa E Paavola; Anne M Remes; Marika J Harila; Tarja T Varho; Tapio T Korhonen; Kari Majamaa
Journal:  J Neurodev Disord       Date:  2015-07-13       Impact factor: 4.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.